Splicing targeting drugs highlight intron retention as an actionable vulnerability in advanced prostate cancer.

J Exp Clin Cancer Res · 2024 · PMC10898177 · PMID 38413979

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The same ALE was also upregulated by indisulam, albeit it did not reach statistical significance in our analysis (Supplementary Fig.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.